Effect of heel elevation in Parkinsonan gait

足跟抬高对帕金森步态的影响

基本信息

批准号：
12832013
负责人：
ETO Fumio
金额：
$ 2.62万
依托单位：
The University of Tokyo
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2000
资助国家：
日本
起止时间：
2000 至 2002
项目状态：
已结题

项目摘要

The effects of heel elevation of shoes on an abnormal gait of Parkinson's disease patients were investigated by using the Gait Scan and the F Scan. These measurements provided several gait parameters including walking speed, step length, step width, cadence, and distribution of plantar pressure. Twenty-five total patients with Parkinson's disease (Hoehn and Yahr stage : III-IV) and 16 total age-matched health people participated in this study. Heel elevation was evaluated with blocks placed beneath the heel that simulated shoes at four different heel heights ; 0, 1.0, 1.5, 2.0 cm. The pathway of the center of pressure, COP pathway, increased at the conditions with heel elevation compared with that without heel elevation. In the age-matched control group, the COP pathway also increased at the conditions with heel elevation. Compared with the age-matched control subjects without any gait disturbances, the patients with Parkinson's disease showed shorter COP pathway at any types of heel elevation. Another effects of heel elevation on Parkinsonian gait included hastening cadence, and shortening transitional time between the two pressure peaks. Parkinson's disease patients appeared to be able to walk with a gait pattern similar to the normal subjects by heel elevation. The influence of heel elevation was obviously in the measurements of walking, and it contributed to the improvement of gait in the Parkinson's disease patients through additional heel elevation of 1.0-2.0cm. These findings suggest the necessity of a further clinical trial with a large-scale sample to establish clinical utility of shoe modification in the patients with Parkinson's disease.

使用步态扫描和F扫描研究了鞋子升高鞋子对帕金森氏病患者步态异常的影响。这些测量值提供了几个步态参数，包括步行速度，步长，步长，柔韧性和足底压力的分布。帕金森氏病（Hoehn和Yahr阶段：III-IV）和16名年龄匹配的健康人参加了25例患者。评估了脚跟高度，并放置在脚后跟下方，以模拟四个不同的脚跟高度的鞋子。 0、1.0、1.5、2.0厘米。与没有脚跟抬高的情况相比，压力中心COP通路的途径在脚跟高度的情况下增加。在年龄匹配的对照组中，在脚后跟抬高的条件下，COP途径也增加了。与没有任何步态障碍的年龄匹配的对照受试者相比，帕金森氏病的患者在任何类型的脚跟抬高时表现出更短的COP途径。脚跟抬高对帕金森氏症步态的另一个影响包括加快节奏以及两个压力峰之间的过渡时间。帕金森氏病患者似乎可以通过脚跟抬高的步态模式行走类似于正常受试者。脚跟抬高的影响显然是在步行的测量中，这导致了帕金森氏病患者的步态改善，而又有1.0-2.0厘米的脚跟升高。这些发现表明，需要进行大规模样本的进一步临床试验，以在帕金森氏病患者中建立鞋子修饰的临床实用性。